Keywords

ADPKD, autosomal dominant polycystic kidney disease, chronic kidney disease, CKD, end-stage renal disease, ESRD, genetic disorder, PKD, polycystic kidney disease, RAAS, renin-angiotensin-aldosterone system, tolvaptan

 

Authors

  1. Uko, Chigozie G. DNP, APRN, FNP-C

Abstract

Abstract: Autosomal dominant polycystic kidney disease causes chronic kidney disease and end-stage renal disease. Mechanisms include cyst production, multiplication, and enlargement leading to increased kidney size, and ultimately kidney failure. Although there is no known cure, NPs are uniquely positioned to help patients manage their symptoms and delay onset of kidney failure and need for dialysis.